South American Gold Set To Acquire Medical Device Company Rehaba

Print
| Source: South American Gold Corp.

Las Vegas, NV , June 09, 2017 (GLOBE NEWSWIRE) -- South American Gold Corp (OTC: SAGD) is proud to announce that it has reached an agreement to acquire Rehaba.  Rehaba, founded and led by Greg Westfall, is the home of the TeslaMax TIER 4 “Mini” Combo unit, an electrical stimulation technology which has 510K marketing clearance by the FDA, as well as ZoneRX, a revolutionary patent pending targeted exercise postural restoration device (which is exempt from FDA requirements).

About TeslaMax:

TeslaMax is a breakthrough electrical stimulation technology with a wide range of applications for both nerve pain relief and as a urinary incontinence treatment. It has a unique ability to create massive muscle contractions without causing pain or discomfort for the patient. This stimulates nearby muscles, causing them to contract. The deeper the muscle contractions, the more pronounced the benefits, which include increased muscle tone, improved circulation, reduced fluid build-up, and accelerated wound healing.

The Tesla-Based Technology in the TeslaMax uses a proprietary form of alternating current (AC) not available in any other electrical stimulation device. With alternating current, the direction of electricity changes directions rapidly, up to 60 times per second. This reduces the amount of heat and friction that builds up in the skin, and it allows for stronger, deeper muscle contractions without pain or risk of electrical burns. This makes it an excellent option when patients are looking for a pain-free treatment for neuropathy and both male and female incontinence.

About ZoneRX:

ZoneRX is a piece of non-medical equipment that teaches the user how to use underutilized zone rx 1muscles that have atrophied. ZoneRX guides them to inhibit chronic abnormal neurological patterns that are locked into the soft tissue, creating new muscle memory that brings the proper muscles back into service.

SAGD President, David Reeves, stated, “With the completion of the acquisition of Rehaba, we will bring value and added revenue to SAGD. This acquisition is a positive step forward in our vision.”

Rehaba’s TeslaMax product is presently available throughout various doctors’ offices and clinic within the United States and Rehaba is furthering the development of its distribution options for international opportunities.

Please see the following informational site links on Rehaba and its products:

Rehaba

TeslaMax

ZoneRX

The TelsaMax product has been used by individuals ranging from the general public for relief of multiple different elements, including diabetic ulcers, to world renowned strength endurance record holder Dr. Nick Delgado to former U.S. Congresswoman Diane Watson.  

The completion of this acquisition creates a revenue producing medical division for SAGD, allowing the company to further the growth of Rehaba, while providing the company’s development division, under the direction of Mr. Bonner, with a basis to further explore other possible opportunities in this space.

SAGD anticipates consummating this acquisition by the end of this month.

Corporate Website: www.sagdcorp.co

Media contact: info@sagdcorp.co

General contact: info@sagdcorp.co

About SAGD: South American Gold Corp is a publicly traded company on the OTC under the symbol SAGD.

Disclaimer: This release contains forward-looking statements that are based on beliefs of South American Gold Corp. management and reflect South American Gold Corp.'s current expectations as contemplated under section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities and Exchange Act of 1934, as amended. When we use in this release the words "estimate," "project," "looks," "believe," "anticipate," "intend," "expect," "plan," "predict," "may," "should," "will," "can," the negative of these words, or such other variations thereon, or comparable terminology, are all intended to identify forward looking statements. Such statements reflect the current views of South America Gold Corp. with respect to future events based on currently available information and are subject to numerous assumptions, risks and uncertainties, including but not limited to, risks and uncertainties pertaining to development of mining properties, changes in economic conditions and other risks, uncertainties and factors, which may cause the actual results, performance, or achievement expressed or implied by such forward looking statements to differ materially from the forward looking statements. The information contained in this press release is historical in nature, has not been updated, and is current only to the date shown in this press release. This information may no longer be accurate and therefore you should not rely on the information contained in this press release. To the extent permitted by law, South American Gold Corp. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission. This press release may incorporate by reference the Company's reports and other filings. Investors are encouraged to review all filings. There is no assurance South American Gold Corp. will identify projects of merit or if it will have sufficient financing to implement its business plan. There is no assurance that the Company's due diligence on the potential projects and/or acquisitions will be favorable nor that definitive terms can be negotiated. Investors should consult their financial advisor before making an investment in a company.